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Irritant dermatitis represents innate in£ammatory
responses to toxic chemicals.We have reported recently
that ATP released from chemically injured keratino-
cytes may serve as a causative mediator for irritant der-
matitis. In this study, we examined whether ATP release
from keratinocytes would serve as a reliable readout for
predicting skin irritating potentials of structurally di-
verse compounds. A vast majority (19/20) of the tested
compounds, i.e., strong and weak irritant chemicals se-
lected from the literature, induced rapid (o10 min) and
signi¢cant (Po0.05) ATP release from Pam 212 kerati-
nocytes. Two compounds caused no detectable skin in-
£ammation in our standard mouse model, documen-
ting relatively high sensitivity (false negative rate of
0/18) and speci¢city (false positive rate of 1/20) of our
ATP release assay. Selected compounds, primarily those
containing phenol residues or hydrophobic hydrocar-
bon chains, triggered rapid (o10 min) and robust leak-
age of a £uorescence probe from liposomes, suggesting
that lipid bilayers serve as one, but not the only, target
moiety on keratinocytes. Not only do our data support
the pathogenic role for keratinocyte-derived ATP in
irritant dermatitis, they also form the basis for a
formal validation study to evaluate the utility of the
keratinocyte-based in vitro assay in screening environ-
mental and industrial chemicals. Key words: irritant che-
micals/in vitro testing/ contact dermatitis. J Invest Dermatol
121:1066 ^1072, 2003
C
ontact dermatitis is classi¢ed into allergic dermatitis
and irritant dermatitis based on the clinical features
and causative chemicals. Allergic dermatitis is now
known to represent Tcell-mediated, antigen-speci¢c
adaptive immune responses to reactive haptens.
Upon topical application of haptens, Langerhans cells (LC) begin
to exhibit characteristic features of mature dendritic cells (DC)
and migrate to the draining lymph nodes, where LC activate hap-
ten-reactive CD8þ e¡ector T cells (Gocinski and Tigelaar, 1990;
Xu et al, 1996; Grabbe and Schwarz, 1998). On the other hand,
irritant dermatitis represents innate in£ammatory responses to
irritant chemicals. Little information, however, is available with
respect to its pathogenic mechanisms.
Pathophysiologic roles played by extracellular ATP and ADP as
proin£ammatory mediators have been studied extensively, espe-
cially in the ¢eld of vascular biology. Nucleotides can be released
extracellularly as a consequence of cell lysis or exocytosis of spe-
cialized secretory vesicles (e.g., platelet-dense bodies). Nucleotide
release can also be triggered by various environmental stimuli,
including mechanical shear forces, stretch, changes in osmolarity,
oxidative stress, and microbial products (Cotrina et al, 1998;
Ferrari et al, 1997; Lazarowski et al, 1997; Roman et al, 1997; Hamada
et al, 1998; Mitchell et al, 1998; Imai et al, 2000). Extracellular nu-
cleotides, in turn, bind to the purinergic type 2 receptors and reg-
ulate cell death, growth, di¡erentiation, migration, and cytokine
production (La Sala et al, 2003; Ralevic and Burnstock, 1998;Wil-
liams and Jarvis, 2000).The nucleotide^purinergic type 2 receptor
cascade is negatively regulated by nucleoside triphosphate dipho-
sphohydrolases, which hydrolyze ATP and ADP into AMP
(Zimmermann, 2000). CD39 was originally identi¢ed as an activa-
tion marker expressed by B cells,Tcells, natural killer cells, and DC
(Kansas et al, 1991; Maliszewski et al, 1994) and subsequently de¢ned
as endothelial cell-associated ecto-nucleoside triphosphate dipho-
sphohydrolase (Kaczmarek et al, 1996;Wang and Guidotti, 1996).
Working with the CD39-de¢cient mice, we recently made
several intriguing observations (Mizumoto et al, 2002). First,
CD39^/^ mice were indistinguishable from CD39þ/þ mice in
the number, distribution, or morphology of epidermal LC de-
¢ned by surface expression of IA molecules and DEC205,
whereas those LC in CD39^/^ mice showed no detectable ecto-
nucleoside triphosphate diphosphohydrolase activities. This indi-
cates that CD39 is responsible for LC-associated ecto-ATPase/
ADPase activities, which have been used 430 years as LC mar-
kers (Wol¡ and Winkelmann, 1967; Chaker et al, 1984). Second,
compared to the wild-type counterpart, CD39^/^ mice exhibited
markedly exacerbated irritant dermatitis responses to each of the
three tested chemicals: croton oil, benzalkonium chloride, and
ethyl phenylpropiolate. On the other hand, experimentally
induced ‘‘sunburn reactions’’ to ultraviolet B irradiation were com-
parable between CD39^/^ mice and wild-type mice, whereas
allergic contact dermatitis responses to a reactive hapten,
oxazolone, were severely attenuated in CD39^/^ mice, docu-
menting opposing outcomes of CD39 de¢ciency in di¡erent
forms of skin in£ammation. Finally, the Pam 212 keratinocyte
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line as well as normal keratinocytes freshly isolated from wild-
type mice released ATP and ADP rapidly upon exposure to each
of the above irritant chemicals (but not to ultraviolet B irradia-
tion). Locally injected ATP induced signi¢cant ear swelling
responses in wild-type mice. Conversely, irritant dermatitis re-
sponses to croton oil in wild-type mice were inhibited signi¢-
cantly, albeit partially, by local injections of soluble nucleoside
triphosphate diphosphohydrolase (potato apyrase). These observa-
tions imply that extracellular nucleotides released from keratino-
cytes upon chemical injury may function as causative mediators
in irritant dermatitis (Mizumoto et al, 2002). On the other
hand, two key questions remain to be addressed. Is this pathway
applicable to a broader spectrum of irritant chemicals with struc-
tural diversity? Do irritant chemicals cause leakage of nucleotides
from the intracellular pools by simply disrupting membrane
lipid bilayers? This study was therefore conducted to address
these speci¢c questions.
MATERIALS AND METHODS
Animals and cells BALB/c mice were bred and maintained in the
Animal Research Center facilities at University of Texas Southwestern
Medical Center. All the animal experiments were approved by the
Institutional Review Board and carried out according to guidelines of the
National Institutes of Health. The murine keratinocyte line Pam 212
(Yuspa et al, 1980) was expanded in the Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% fetal calf serum as before (Matsue et al,
1993). The human keratinocyte line A431 was purchased from the
American Type Culture Collection (Manassas, VA) and maintained in the
above medium. Normal human keratinocyte cultures were purchased from
Cambrex (Walkersville, MD) and expanded in the KBM-2 medium; cells
of the third or fourth passage were used in the experiments.
Keratinocyte-based ATP release assay Irritant chemicals were
purchased from Sigma-Aldrich (St. Louis, MO), TCI America (Portland,
OR), Alfa Aesar (Ward Hill, MA), ICN Biomedical (Cleveland, OH), or
Fisher Scienti¢c (Pittsburgh, PA). Dinitro£uorobenzene (DNFB) and
dinitrobenzene sulfonic acid (DNBS) were purchased from Sigma. None
of the above reagents contained detectable amounts of endotoxin as tested
by the QCL-100 system (BioWhittaker,Walkersville, MD). The Pam 212
and A431 keratinocyte lines (5105 cells/well, 6-well plates) or normal
human keratinocytes (4105 cells/well, 12-well plates) were cultured in
the respective growth medium for 24 h, washed with phosphate-bu¡ered
saline (PBS), and exposed to each test chemical at graded concentrations in
PBS for 10 min at room temperature. The supernatants were centrifuged at
4000 g for 3 min through 10% bovine serum albumin in PBS to remove
any cellular debris and then examined for ATP concentrations using the
luciferin^luciferase assay kit (Sigma) (Mizumoto et al, 2002). ATP
concentrations in test samples were compared with the baseline ATP level
detected in the negative control keratinocyte cultures treated with PBS
alone. All compounds were also examined at graded concentrations for
their direct impact on luciferase activities.
Liposome disruption assay To study the impact of test chemicals on
lipid bilayers, liposomes containing an alkaline phosphatase (ALP)-
sensitive £uorescence dye were prepared by the detergent dialysis method.
Brie£y, solutions of L-a-phosphatidylcholine:L-a-phosphatidylethanolmine:
cholesterol 30 -N-(dimethylaminoethyl)-carbamate (10:2.5:2.5) in chloroform:
methanol (1:1) were evaporated to dryness under nitrogen in borosilicate
tubes. Films were further dried overnight at room temperature under
vacuum before resuspending in 10 mM Tris^HCl/150 mM NaCl, pH 7.2,
containing £uorescein diphosphate (5.6 mg/mL). Lipid suspensions were
clari¢ed by addition of n-octyl-b-D-glucopyranoside at a molar ratio of
0.4 relative to L-a-phosphatidylcholine followed by dialysis with the
LipoPrep device (Harvard Apparatus, Holliston, MA) using a molecular
weight cuto¡ of 5000 Da. Dialysis was continued for 2 h at 401C, and
residual detergent was removed by chromatography with an excellulose
desalting column from Pierce Chemical (Rockford, IL). The resulting
liposome preparations were incubated with each test compound for 10
min at room temperature, and the leakage of £uorescein diphosphate was
examined by measuring the £uorescence signals after ALP treatment. All
test compounds were also examined at graded concentrations for their
direct impact on ALP activities.
In vivo testing of skin irritating potentials Test compounds,
excluding those classi¢ed as corrosive chemicals, were examined for their
in vivo properties using our standard mouse model of irritant dermatitis
(Mizumoto et al, 2002). Test compounds were diluted in distilled water
and applied topically on the ear of BALB/c mice (8^10 weeks old, female)
in the absence of any carriers or vehicles. The ear thickness was then
measured at di¡erent time points by a third blinded experimenter using a
micrometer.
RESULTS
Sensitivity of keratinocyte ATP release assay with the Pam
212 indicator We selected 20 test compounds based on their
skin irritancy potentials reported in the literature (Bagley et al,
1995; Barratt et al, 1998), structural diversity, and availability from
commercial sources. This collection contained 11 corrosive
chemicals and 9 noncorrosive, skin irritants (Fig 1). Each
compound was diluted in PBS to make serial dilutions from
0.01% (vol/vol) to 10% and then added to Pam 212 murine
keratinocyte monolayers. After 10 min of incubation at room
temperature, we examined ATP concentrations in the super-
natants. Compared with the negative control of PBS alone, all
tested compounds including both corrosive and noncorrosive
chemicals, except for propylene glycol, induced signi¢cant ATP
release in concentration-dependent fashions, as shown with red
lines in Fig 2. It should be noted that we failed to correlate
quantitatively the known in vivo activities of the test compounds
to cause skin irritation to the maximal magnitudes of ATP release
(ranging from o0.1 to 8 mM) or the minimal compound doses
required for triggering signi¢cant ATP release (ranging from
0.03% to 10%).
ATP release by human keratinocytes Three representative
irritants, heptylamine, butylphenol, and sodium dodecyl sulfate
(SDS), were also tested for their impact on human keratinocytes.
It should be stated that the human keratinocyte experiments were
performed as an open trial, independently from the above
double-blinded study with Pam 212 keratinocytes. Compared
with the negative control of PBS alone, each compound
triggered signi¢cant ATP release from the A431 human
keratinocyte line in a concentration-dependent fashion (Fig 3A).
The A431 keratinocyte line was roughly comparable to the Pam
212 line in terms of their responsiveness (i.e., concentration
-dependency and magnitude of ATP release) to the three
irritants. Moreover, each of these irritant chemical also induced
signi¢cant ATP release from normal human keratinocyte
cultures (Fig 3B). These observations support the concept that
extracellular nucleotides released from chemically injured
keratinocytes play pathogenic role(s) in the development of
irritant dermatitis.
Keratinocyte responsiveness to reactive haptens Grabbe et al
(1996) demonstrated previously that skin irritation is a required
feature of reactive haptens for producing allergic contact
hypersensitivity responses. Thus, it was of interest to determine
whether some reactive haptens might also trigger ATP release
from keratinocytes. It should be stated that the following
experiments with contact allergens were conducted as an open
study, independently from the double-blinded study with
irritant chemicals shown in Fig 2. DNFB is a prototypic hapten
widely used for studying immunologic bases for allergic contact
dermatitis; this compound is typically applied at 0.1% to 0.5%
(approximately 10^50 mM) for sensitization and at 0.2% to 0.3%
(20^30 mM) for elicitation. On the other hand, DNBS is a water-
soluble derivative of DNFB and primarily used for in vitro pulsing
of antigen-presenting cells at 1 to 10 mM. Mice sensitized by
administration of DNBS-pulsed DC exhibit signi¢cant allergic
contact hypersensitivity upon topical challenge with DNFB.
Despite the similarities in their putative antigenic epitopes
and chemical structures (Fig 4A), these two compounds di¡ered
strikingly from each other in their impact on keratinocytes.
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DNFB triggered ATP release from Pam 212 keratinocytes in a
concentration-dependent fashion, with signi¢cant release indu-
cible at 10 mM and more robust e¡ects at higher concentrations
(100^300 mM) (Fig 4B). By marked contrast, DNBS caused no
detectable ATP release at 10 to 30 mM and induced signi¢cant,
but only marginal ATP release at 100 to 300 mM. Not only do
our observations support the concept proposed by Grabbe et al,
they also illustrate chemical structure-dependence of the ATP
release phenomenon.
In vivo testing of noncorrosive, skin irritant chemicals
Because all corrosive chemicals in the test panel shown in Figs 1
and 2 are well known to induce severe skin in£ammation in the
literature (Bagley et al, 1995), we next examined noncorrosive
chemicals and potassium hydroxide (which is classi¢ed as
noncorrosive at 5%) in our animal model of irritant dermatitis.
Eight compounds at the tested concentrations (5%^100%)
induced signi¢cant ear swelling responses in various degrees,
whereas isopropanol and propylene glycol, which have been
reported as mild skin irritants (Warshaw and Herrmann, 1952;
Bagley et al, 1995), produced no detectable responses even at
100% (Fig 5). The in vivo and in vitro data sets document
relatively high sensitivity (false-negative rate 0 of 18) and
speci¢city (false-positive rate 1 of 20) of our ATP release assay
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Figure1. Chemical structures and in vivo skin-irritating potentials of the test compounds. Corrosive chemicals are indicated with asterisks. Animal
test results are shown in parentheses, whereas the human 4-h patch test results are shown in brackets. In the Draize test, the samples causing rapid (o4 h)
and irreversible changes penetrating into dermis are classi¢ed as corrosive chemicals, whereas those causing erythema and edema after prolonged exposure
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against corrosive and noncorrosive compounds with structural
diversity and varying degrees of skin irritant potentials.
Putative mechanisms for ATP release from keratinocytes
We reasoned that some chemicals (e.g., surfactants) may cause
ATP leakage from the intracellular ATP pools (5^10 mM) by
disrupting membrane lipid bilayers. To test this mechanism, we
developed a liposome-based in vitro assay by encapsulating an
ALP-sensitive £uorescence probe, £uorescein diphosphate, in
liposomes. Because the probe becomes accessible to ALP-
mediated activation only after release from the liposomes, this
assay allows easy measurement of liposomal disruption without
separation of intact liposomes by ultracentrifugation. Moreover,
in preliminary experiments, the extent of variations was within
10% of the mean values from triplicate samples, suggesting an
additional advantage of this cell-free assay (data not shown). The
liposome preparations were incubated for 10 min with each
test compound at di¡erent concentrations and then examined
for £uorescence signals after ALP treatment. As expected, a
prototypic surfactant, SDS, disrupted the liposomes e⁄ciently,
inducing concentration-dependent release of £uorescence probes
(shown with blue lines in Fig 2). Interestingly, this concentration^
response curve was almost superimposable with that for SDS-
induced ATP release from keratinocytes (shown with red lines in
Fig 2). Apparent liposomal disruption was also caused by some
of the corrosive and noncorrosive chemicals, mainly those
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Figure 2. In vitro test results with the Pam 212 keratinocyte-based ATP release assay and the liposome disruption assay. Pam 212 keratinocytes
were incubated for 10 min at room temperature with each chemical at the indicated concentrations. The supernatants were then examined for ATP concen-
trations by the standard luciferin^luciferase assay (means7SD, n¼ 3, po0.05 and po0.01 compared to the negative control treated with PBS alone)
(red lines). Liposomes containing £uorescein diphosphate were incubated for 10 min with each chemical at the indicated concentrations. The samples were
then examined for £uorescence signals after activation with ALP (blue lines). None of the compounds directly a¡ected the enzymatic activities of luciferase or
ALP in the concentration ranges shown in this ¢gure. Data shown are representative of at least two independent experiments.
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Figure 3. ATP release from human keratinocytes.The human kerati-
nocyte line A431 (A) or normal human keratinocyte cultures (B) were
exposed for 10 min to each of the three irritants at the indicated concentra-
tions and the supernatants were examined for ATP concentrations
(means7SD, n¼ 3, po0.01 compared to the negative control with PBS
alone). Data shown are representative of two independent experiments.
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containing phenol residues (e.g., butylphenol, carvacrol, and
eugenol) or hydro-phobic hydrocarbon chains (e.g., octanoic acid,
cetyltrimethylammonium bromide, and decanol). By contrast,
only marginal, if any, liposome disruption was induced by
other compounds including corrosive compounds, such as amine-
containing organic bases (e.g., diaminopropane, methoxypro-
pylamine, dimethylisopropylamine, heptylamine, and piperazine)
and inorganic bases (e.g., sodium hydroxide and potassium
hydroxide). These observations imply that perturbation of lipid
bilayers on keratinocytes is one, but not the only, mechanism by
which irritant chemicals induce ATP release.
DISCUSSION
This study was conducted to address two speci¢c questions: Can
we apply the keratinocyte ATP release assay to a broader spec-
trum of irritant chemicals? Do irritant chemicals induce ATP re-
lease by simply disrupting plasma membrane? With respect to the
¢rst question, signi¢cant ATP release from Pam 212 keratinocytes
was induced by all tested corrosive and noncorrosive chemicals,
except for propylene glycol. Our subsequent in vivo testing re-
vealed two compounds (propylene glycol and isopropanol) that
failed to produce irritant dermatitis in our animal model. Taken
together, these results document relatively high sensitivity and
speci¢city of our assay to structurally diverse chemicals. With
regard to the second question, several compounds were found to
induce robust release of £uorescence probes from liposomes, cor-
roborating the previous reports with surfactants (Charaf and
Hart, 1991; Kato et al, 1988). Nevertheless, other compounds, in-
cluding some corrosive chemicals, caused only marginal, if any,
liposome disruption. Thus, lipid bilayers appear to serve as a rele-
vant target for only selected compounds (e.g., those containing
phenol residues or hydrophobic carbon chains). Identities of addi-
tional target moieties remain unknown at present.
The Draize rabbit skin test has served for450 years as a world
standard for evaluating the corrosive and skin-irritating proper-
ties of industrial chemicals. Although the procedure has been
modi¢ed by di¡erent regulatory authorities, this test basically
measures the severity, speed of onset, and persistence/reversibility
of skin reactions following application of test samples to shaved
rabbit skin under an occlusive or semiocclusive dressing. To over-
come intrinsic problems (e.g., poor reliability for human subjects
owing to interspecies variations and subjective nature of the read-
outs) of the Draize irritancy test and to avoid social con£icts with
animal welfare organizations, the human 4-h patch test has been
developed as an alternative in vivo testing (Gri⁄ths et al, 1997;
Robinson et al, 2001). On the other hand, this approach may not
be suitable for testing large numbers of potentially hazardous
chemicals being introduced each year to the workplace and con-
sumer products. Many di¡erent in vitro tests have therefore been
developed by using: (1) skin specimens or skin-equivalent organ
cultures; (2) keratinocyte, ¢broblast, and endothelial cell cultures;
and (3) in vitro reconstituted biomolecules (e.g., liposomes and
synthetic protein matrix). These materials are incubated with
test chemicals and then examined for: (1) histologic integrity
and electrical conductivity; (2) cell viability, cytokine release,
growth, di¡erentiation, and metabolism; and (3) permeability to
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Figure 5. In vivo test results with a mouse model of irritant dermatitis.The test compounds, except for those that are classi¢ed as corrosive chemicals,
were examined for their in vivo potentials to produce irritant dermatitis in our mouse model. BALB/c mice (¢ve mice/panel) received topical application of
each chemical at the indicated concentration and were then examined for ear swelling responses after 20 min and 4, 24, 48, and 72 h (means7SEM).
Statistically signi¢cant di¡erences are indicated with asterisks (po0.05 and po0.01). Data are representative of two independent experiments.
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£uorescence probes and turbidity of the matrix (Herzinger et al,
1995). Osborne and Perkins (1994) postulated several requirements
for ideal in vitro tests: (1) broad-range responsiveness to structu-
rally unrelated chemicals (to ensure high sensitivity); (2) measure-
ment of common and pathogenic events as endpoints (to provide
biologically meaningful information); and (3) transferability to
di¡erent laboratories (to serve as a universal standard). Unfortu-
nately, currently available in vitro tests fail to fully satisfy these re-
quirements (Herzinger et al, 1995).
Our ATP release assay has several advantages over other kerati-
nocyte-based assays. First, our assay is designed to measure the
primary change in the pathogenesis of irritant dermatitis. Signif-
icant ATP release occurs within 5 to 10 min after exposure to ir-
ritant chemicals, whereas conventional readouts are measured at
later time points (e.g., 1^72 h after treatment). Keratinocyte pro-
duction of interleukin-1a and interleukin-8 has been observed
typically after 3 to 24 h exposure to SDS at a concentration range
from 0.001% to 0.01% (Mˇller-Decker et al, 1994; Wilmer et al,
1994; E¡endy et al, 2000). Release of a cytoplasmic enzyme lactate
dehydrogenase is often monitored as a readout of cell death or
plasma membrane disruption. In this regard, signi¢cant lactate
dehydrogenase release from skin organ cultures has been reported
to require a 4-h exposure to 1% SDS (van de Sandt et al, 1995).
Likewise, we observed previously in the Pam 212 keratinocyte-
based assays that signi¢cant lactate dehydrogenase release required
3- to 10-fold higher concentrations of croton oil and benzalko-
nium chloride than those for triggering signi¢cant ATP release
(Mizumoto et al, 2002). Thus, it appears that ourATP release assay
is roughly comparable with cytokine production assays and more
sensitive than lactate dehydrogenase release assays in terms of
concentration dependency to test chemicals.
A second major advantage is that ATP release may represent a
causative event in irritant dermatitis. Our observations that
mouse and human keratinocytes both released ATP upon expo-
sure to irritant chemicals further support this notion.With regard
to mechanisms, ATP treatment of keratinocytes has been re-
ported to trigger Ca2þ mobilization, inhibit terminal di¡erentia-
tion, regulate proliferation, and induce apoptosis (Suter et al, 1991;
Pillai and Bikle, 1992; Girolomoni et al, 1993; Pillai et al, 1995).
From the recent viewpoint that extracellular nucleotides act as
‘‘endogenous danger signals’’ by activating DC (La Sala et al,
2003), epidermal LC may be considered as a second target. LC
in human skin have been reported to exhibit characteristic fea-
tures of mature DC (e.g., morphologic changes and/or migration
from the epidermis) after topical application of croton oil, SDS,
nonanoic acid, or dithranol (Willis et al, 1990). Rapid morpholo-
gic changes have been observed at the electron microscopic level
in human LC after SDS application (Mikulowska et al, 1988).
Some of these changes may be induced by keratinocyte-derived
ATP because DC isolated from various tissues (including skin)
have been shown to express mRNAs for a variety of purinergic
type 2 receptors and because ATP (and ADP) are known to reg-
ulate Ca2þ in£ux, phenotypic maturation, chemotactic migra-
tion, cytokine/chemokine production, and apoptosis in DC
(Mutini et al, 1999; Ferrari et al, 2000; Berchtold et al, 1999; Cou-
tinho-Silva et al, 1999; Liu et al, 1999; Marriott et al, 1999; La Sala
et al, 2001, 2002). Thus, extracellular ATP may play a pathogenic
role by orchestrating purinergic type 2 receptor-dependent proin-
£ammatory changes in the skin.
Finally, our assay provides quantitative and objective readouts
with relatively small sample-to-sample variations. Moreover, the
assay procedure is fully compatible to a high-throughput screen-
ing format and readily transferable to di¡erent laboratories. These
advantages, together with the overall sensitivity and speci¢city,
support the practical utility of keratinocyte ATP release assay as
the ¢rst screening platform for testing large numbers of environ-
mental and industrial chemicals.
Two structurally similar haptens (DNFB and DNBS) were
found to di¡er from each other in their potentials to induce
ATP release, documenting chemical structure dependence of our
assay and supporting the notion proposed by Grabbe et al (1996)
that at least some contact sensitizers also function as skin irritants.
These observations may ¢rst appear to be contradictory to our
previous report that CD39^/^ mice, which are defective in
CD39-dependent hydrolysis of extracellular ATP, exhibit signi¢-
cantly exacerbated irritant dermatitis and severely impaired aller-
gic dermatitis (Mizumoto et al, 2002). It should be stated,
however, that the latter phenotype most likely re£ects the
functional abnormality (i.e., ATP unresponsiveness owing to
purinergic type 2 receptor desensitization) of CD39^/^ DC
in their ATP-mediated communication with T cells during anti-
gen presentation, the process that is required for allergic, but not
irritant, contact hypersensitivity responses.
It is equally important to note several pitfalls of our ATP re-
lease assay. First, it is not designed to re£ect relative penetration
of test chemicals through the stratum corneum or their interac-
tion with intrinsic bu¡ering molecules. In fact, this limitation
may be responsible for our failure to correlate quantitatively the
in vitro potentials of the tested chemicals to trigger ATP release to
their in vivo skin irritancy potentials. Second, our assay is not sui-
table for testing solid samples or water-insoluble materials. These
shortcomings, which are shared with many cell-based assays,
should be taken into consideration before conducting large-scale
screening operations. Nevertheless, we believe that this study
forms the basis for conducting a multilaboratory, formal valida-
tion study with a larger number of structurally unrelated test
compounds.
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